Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mTOR in Exercise-induced Insulin Sensitivity
NCT05233722Recruiting
- Sponsor
- University of Copenhagen
- Start
- Feb 2022
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Rapamycin with Placebo (2 arms). Primary endpoint: Insulin stimulated muscle glucose uptake. Started Feb 2022; status: recruiting.
02
Drugs
sirolimus
Beyond the preview
Go deeper on NCT05233722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05233722.